Page last updated: 2024-10-25

chlorpropamide and Peripheral Arterial Disease

chlorpropamide has been researched along with Peripheral Arterial Disease in 1 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Peripheral Arterial Disease: Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CANGI, G1
LOMBARDI, V1
MATTII, R1

Other Studies

1 other study available for chlorpropamide and Peripheral Arterial Disease

ArticleYear
[Further clinical experiences on the action of some derivatives of sulfonylurea in peripheral arteriopathies of sclerotic nature].
    Giornale di gerontologia, 1962, Volume: 10

    Topics: Chlorpropamide; Hypoglycemic Agents; Peripheral Arterial Disease; Peripheral Vascular Diseases; Sulf

1962